New vaccine trial aims to train body to attack lung cancer
Disease control
Recruiting now
This study is testing a vaccine designed to teach the body's immune system to recognize and fight non-small cell lung cancer. It is for patients with early-stage or locally advanced lung cancer who have recently finished standard treatment. The main goal is to see if the vaccine …
Phase: PHASE1, PHASE2 • Sponsor: Olivera Finn • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC